What the research examined
An analysis of neurological-disease trials examined weight changes associated with tesofensine and also reported heart-rate changes. A separate study investigated appetite sensations and how their relationship to weight changed over time.
How to interpret the findings
Subjective appetite ratings, body weight, and cardiovascular measurements must be considered separately. A secondary analysis in a neurological-disease population cannot establish universal effects. Tesofensine is a small molecule, not a peptide.
Research literature
- Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease.
Obesity (Silver Spring, Md.) · 2008 · PMID 18356831 - The effect of tesofensine on appetite sensations.
Obesity (Silver Spring, Md.) · 2012 · PMID 21720440
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.